BS
Ballard Spahr LLP
More
Ballard Spahr LLP—an Am Law 100 law firm with more than 750 lawyers in 18 U.S. offices—serves clients across industries in litigation, transactions, and regulatory compliance. A strategic legal partner to clients, Ballard goes beyond to deliver actionable, forward-thinking counsel and advocacy powered by deep industry experience and an understanding of each client’s specific business goals. Our culture is defined by an entrepreneurial spirit, collaborative environment, and top-down focus on service, efficiency, and results.
Ryan Udell will moderate a discussion between Chong Xu of F-Prime Capital and Hugh Davis of Aclaris Therapeutics at Life Sciences PA’s annual meeting.
United States
To print this article, all you need is to be registered or login on Mondaq.com.
Ryan Udell, co-leader of Ballard Spahr’s Life Sciences Industry Team, will speak at
Life Sciences PA’s annual Life Sciences Future meeting. Ryan
will be moderating a conversation between Chong Xu, Partner at
F-Prime Capital, and Hugh Davis, Ph.D., Chief Operating Officer and
President of Aclaris Therapeutics, Inc.
The event description:
Clinical research and deals are increasingly crossing
borders, creating new opportunities and challenges for the life
sciences industry. This panel will explore the benefits, tradeoffs,
and lessons learned from conducting global clinical trials. Hear
perspectives from large and emerging biopharma companies and
policymakers as they discuss how international clinical research
and dealmaking are driving innovation, improving efficiencies, and
shaping the future of drug development.
Event Details
1
October 2026
9:00 PM – 10:00 PM PST
The Sheraton Valley Forge
480 N Gulph Road
King of Prussia , PA 19406